ADHD medication management is the focus of a new study on optimal doses and the first-ever consensus statement about deprescribing stimulants.

A new Swedish cohort study reveals that nearly half of adults with ADHD and substance use disorder stop medication within one year of a diagnosis, compared to one-quarter of adults with ADHD only.

Treating ADHD with the stimulant medication methylphenidate before age 13 is associated with lower rates of psychosis, psychiatric disorders, and PTSD later in life, suggest two new studies.

Ongoing ADHD care is causing a financial strain, according to ADDitude readers, who report paying unsustainable out-of-pocket costs and employing extreme measures just to stay afloat.

A veteran psychiatrist shares his view of how private health insurance companies dictate — and limit — ADHD care in America.